Skip to main content
SpringerLink
Log in
Book cover

Movement Disorder Emergencies pp 175–185Cite as

Serotonin Syndrome

  • Chapter

Part of the book series: Current Clinical Neurology ((CCNEU))

Abstract

Patient 1: A 34-year-old woman had a history of migraine with aura since age 16 and recent postpartum depression. Approximately 6 months ago, she started fluoxetine for depression and migraine prophylaxis. At her most recent clinic appointment, she also started sumatriptan to abort her migraines. Two weeks later, 1 hour after her third subcutaneous 6-mg dose of sumatriptan, she presented to the emergency room. Her exam showed diaphoresis, agitation, confusion, dysarthria, staggering gait, and occasional myoclonic jerks in the legs.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Oates JA, Sjoerdsma A. Neurologic effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology 1960;10:1076–1078.

    PubMed  CAS  Google Scholar 

  2. Mills KC. Serotonin syndrome. American Family Physician 1995;52:1475–1482.

    PubMed  CAS  Google Scholar 

  3. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705–713.

    PubMed  CAS  Google Scholar 

  4. Harrison’s Principles of Internal Medicine. 15th edition. Braunwald E, Stone RM, Fauci AS, Hauser SL, Jameson JL, eds. McGraw-Hill, New York: 2001.

    Google Scholar 

  5. Siegel GJ, Albers RW, Agranoff BW, et al. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects. 6th edition. Lippincott-Raven, Philadelphia: 1999.

    Google Scholar 

  6. Gillman, PK. Serotonin syndrome: clomipramine too soon after moclobemide. Int Clin Psychopharmacol 1997;12:339–342.

    Article  PubMed  CAS  Google Scholar 

  7. Toyama SC, Iacono RP. Is it safe to combine a selective serotonin reuptake inhibitor with selegiline? Ann Pharmacother 1994;28:405.

    PubMed  CAS  Google Scholar 

  8. Waters CH. Fluoxetine and selegiline-lack of significant interaction. Can J Neurol Sci 1994;21:259–261.

    PubMed  CAS  Google Scholar 

  9. Zornberg GL, Bodkin JA, Cohen BM. Severe adverse interaction between pethidine and selegiline. Lancet 1991;337:246.

    Article  PubMed  CAS  Google Scholar 

  10. Durson SM, Mathew VM, Reveley MA. Toxic serotonin syndrome after fluoxetine plus carbamazepine. Lancet 1993;342:442–443.

    Article  Google Scholar 

  11. Parker V, Wong AHC, Boon HS, Seeman MV. Adverse reactions to St John’s Wort. Can J Psychiatry 2001;46:77–79.

    PubMed  CAS  Google Scholar 

  12. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). American Psychiatric Association, 2000.

    Google Scholar 

  13. Gardner DM, Lynd LD. Sumatriptan contraindications and the serotonin syndrome. Ann Pharmacother 1998;32:33–38.

    Article  PubMed  CAS  Google Scholar 

  14. Mathew NT, Tietjen GE, Lucker C. Serotonin syndrome complicating migraine pharmacotherapy. Cephalalgia 1996;16:323–327.

    Article  PubMed  CAS  Google Scholar 

  15. DeSilva KE, Le Flore DB, Marston BJ, Rimland D. Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine. AIDS 2001;15:1281–1285.

    Article  PubMed  CAS  Google Scholar 

  16. Parrott AC. Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity. Pharmacol Biochem Behav 2002;71:837–844.

    Article  PubMed  CAS  Google Scholar 

  17. Randall T. Ecstasy-fueled “rave” parties become dances of death for English youths JAMA 1992;268:1505–1506.

    Article  PubMed  CAS  Google Scholar 

  18. Gill M, Lo Vecchio F, Seldan B. Serotonin syndrome in a child after a single dose of fluvoxamine. Ann Emerg Med 1999;33:457–459.

    Article  PubMed  CAS  Google Scholar 

  19. Spirko BA, James FW. Serotonin syndrome: A new pediatric intoxication. Pediatr Emerg Care 1999;15(6):440–443.

    Article  PubMed  CAS  Google Scholar 

  20. Graudins A, Stearman, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med 1998;16:615–619.

    Article  PubMed  CAS  Google Scholar 

  21. Nisijima K, Nibuya M, Kato S. Toxic serotonin syndrome successfully treated with electroconvulsive therapy. J Clin Psychopharmacol 2002;22:338–339.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Long Island Jewish Medical Center, New Hyde Park, NY

    Mark Forrest Gordon MD & Adena Leder DO

Authors
  1. Mark Forrest Gordon MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adena Leder DO
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc.

About this chapter

Cite this chapter

Gordon, M.F., Leder, A. (2005). Serotonin Syndrome. In: Movement Disorder Emergencies. Current Clinical Neurology. Humana Press. https://doi.org/10.1385/1-59259-902-8:175

Download citation

  • DOI: https://doi.org/10.1385/1-59259-902-8:175

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-305-3

  • Online ISBN: 978-1-59259-902-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation